Tyra Biosciences, Inc. financial data

Symbol
TYRA on Nasdaq
Location
Carlsbad, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2146% % -25%
Debt-to-equity 6.5% % 21%
Return On Equity -36% % -42%
Return On Assets -34% % -41%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53,372,098 shares 5.5%
Common Stock, Shares, Outstanding 53,318,198 shares 0.84%
Entity Public Float $337,800,000 USD 26%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 59,670,757 shares 1.4%
Weighted Average Number of Shares Outstanding, Diluted 59,670,757 shares 1.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $96,922,000 USD 23%
General and Administrative Expense $29,043,000 USD 35%
Operating Income (Loss) $125,965,000 USD -26%
Nonoperating Income (Expense) $14,281,000 USD -13%
Net Income (Loss) Attributable to Parent $111,684,000 USD -33%
Earnings Per Share, Basic -1 USD/shares -15%
Earnings Per Share, Diluted -1 USD/shares -15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $61,951,000 USD -40%
Assets, Current $281,216,000 USD -23%
Property, Plant and Equipment, Net $1,346,000 USD -25%
Other Assets, Noncurrent $12,590,000 USD 110%
Assets $301,851,000 USD -21%
Accounts Payable, Current $1,991,000 USD 71%
Liabilities, Current $15,879,000 USD 28%
Operating Lease, Liability, Noncurrent $5,463,000 USD -7.7%
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $21,342,000 USD 17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $442,000 USD -75%
Retained Earnings (Accumulated Deficit) $337,424,000 USD -49%
Stockholders' Equity Attributable to Parent $280,509,000 USD -23%
Liabilities and Equity $301,851,000 USD -21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,458,000 USD -16%
Net Cash Provided by (Used in) Financing Activities $2,187,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $32,026,000 USD 77%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 53,318,198 shares 0.81%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,755,000 USD -96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $62,951,000 USD -40%
Deferred Tax Assets, Valuation Allowance $63,267,000 USD 55%
Deferred Tax Assets, Gross $64,806,000 USD 52%
Operating Lease, Liability $5,919,000 USD -6.3%
Depreciation $500,000 USD 25%
Payments to Acquire Property, Plant, and Equipment $14,000 USD -90%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $112,994,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid $8,036,000 USD -9.7%
Property, Plant and Equipment, Gross $2,915,000 USD 16%
Operating Lease, Liability, Current $456,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $900,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $223,000 USD -74%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,117,000 USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year Three $927,000 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $18,938,000 USD 34%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $5,529,000 USD 84%
Lessee, Operating Lease, Liability, to be Paid, Year Four $955,000 USD 0%
Operating Lease, Payments $900,000 USD 80%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $143,000 USD 17%
Deferred Tax Assets, Net of Valuation Allowance $1,539,000 USD -6.3%
Share-based Payment Arrangement, Expense $27,081,000 USD 34%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%